RE: BLQ Data

From: Camille Vong Date: October 02, 2015 technical Source: mail-archive.com
Hi Brady, I think there are three main articles you can refer to in terms of using M3 method for BLQ data: Likelihood based approaches to handling data below the quantification limit using NONMEM VI. http://www.ncbi.nlm.nih.gov/pubmed/18686017 Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models. http://www.ncbi.nlm.nih.gov/pubmed/21626437 Handling data below the limit of quantification in mixed effect models. http://www.ncbi.nlm.nih.gov/pubmed/19452283 As a general rule of thumb, most people tend to ignore(=exclude) the datapoints (not the whole ID) if BLQ data are less than 10%. However, I think it is important to look at where these BLQ data occur mainly to know if they can bring more info into your model and sometimes, having these extra BLQ data left in the analysis and using the M3 method can be better for parameter estimation. Nonetheless beware that M3 method does not always help in terms of run convergence (covariance step). Hope it helps! Best regards, Camille
Quoted reply history
From: [email protected] [mailto:[email protected]] On Behalf Of Moffett, Brady S. Sent: Friday, October 2, 2015 10:23 AM To: [email protected] Subject: [NMusers] BLQ Data I am working with TDM data and am wondering when to use the M3 method for dealing with BLQ data, or, when to just exclude data? For instance: If I have <1% BLQ data in a large dataset (~1000 patients), should I just exclude those patients/values? If I just have one patient with one value BLQ, is it worth using the M3 method for that one patient? Is there a breakpoint for which using these methods does/does not make a difference? Thanks in advance... ______________________________________________________________________ CONFIDENTIALITY NOTICE: The information in this e-mail may be confidential and/or privileged. If you are not the intended recipient or an authorized representative of the intended recipient, you are hereby notified that any review, dissemination, or copying of this e-mail and its attachments, if any, or the information contained herein is prohibited. If you have received this e-mail in error, please immediately notify the sender by return e-mail and delete this e-mail from your computer system. Thank you. ______________________________________________________________________
Oct 02, 2015 Brady S Moffett BLQ Data
Oct 02, 2015 Ahmed Suleiman Re: BLQ Data
Oct 02, 2015 Camille Vong RE: BLQ Data
Oct 02, 2015 Li Li Re: BLQ Data
Oct 02, 2015 Dan Wright Re: BLQ Data